Litcius/Paper detail

Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2

Ilana Schlam, Ruth Moges, Stefania Morganti, Sara M. Tolaney, Paolo Tarantino

2023Critical Reviews in Oncology/Hematology25 citationsDOI

Topics & Concepts

Trastuzumab emtansineTrastuzumabAntibody-drug conjugateMedicinePayload (computing)Breast cancerDrugCalicheamicinCancerCancer researchAntibodyMonoclonal antibodyComputer sciencePharmacologyInternal medicineImmunologyComputer networkNetwork packetHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchRadiopharmaceutical Chemistry and Applications
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2 | Litcius